India · Delayed Price · Currency is INR Anuh Pharma Statistics
Total Valuation
Anuh Pharma has a market cap or net worth of INR 8.10 billion. The enterprise value is 7.57 billion.
| Market Cap | 8.10B |
| Enterprise Value | 7.57B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Aug 5, 2026 |
Share Statistics
| Current Share Class | 100.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 72.69% |
| Owned by Institutions (%) | 0.00% |
| Float | 27.07M |
Valuation Ratios
The trailing PE ratio is 19.73.
| PE Ratio | 19.73 |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.44 |
| EV / Sales | 0.98 |
| EV / EBITDA | 11.17 |
| EV / EBIT | 13.40 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.22 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | -0.01 |
| Interest Coverage | 119.54 |
Financial Efficiency
Return on equity (ROE) is 12.10% and return on invested capital (ROIC) is 12.43%.
| Return on Equity (ROE) | 12.10% |
| Return on Assets (ROA) | 6.63% |
| Return on Invested Capital (ROIC) | 12.43% |
| Return on Capital Employed (ROCE) | 15.93% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | 23.89M |
| Profits Per Employee | 1.27M |
| Employee Count | 295 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 5.48 |
Taxes
In the past 12 months, Anuh Pharma has paid 131.75 million in taxes.
| Income Tax | 131.75M |
| Effective Tax Rate | 24.30% |
Stock Price Statistics
The stock price has decreased by -15.15% in the last 52 weeks. The beta is 0.43, so Anuh Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -15.15% |
| 50-Day Moving Average | 78.53 |
| 200-Day Moving Average | 79.00 |
| Relative Strength Index (RSI) | 53.06 |
| Average Volume (20 Days) | 51,273 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anuh Pharma had revenue of INR 7.72 billion and earned 410.46 million in profits. Earnings per share was 4.10.
| Revenue | 7.72B |
| Gross Profit | 1.63B |
| Operating Income | 564.60M |
| Pretax Income | 542.21M |
| Net Income | 410.46M |
| EBITDA | 673.19M |
| EBIT | 564.60M |
| Earnings Per Share (EPS) | 4.10 |
Balance Sheet
The company has 529.19 million in cash and 583,000 in debt, with a net cash position of 528.61 million.
| Cash & Cash Equivalents | 529.19M |
| Total Debt | 583,000 |
| Net Cash | 528.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.52B |
| Book Value Per Share | 35.14 |
| Working Capital | 2.48B |
Cash Flow
In the last 12 months, operating cash flow was -30.12 million and capital expenditures -78.69 million, giving a free cash flow of -108.80 million.
| Operating Cash Flow | -30.12M |
| Capital Expenditures | -78.69M |
| Depreciation & Amortization | 113.82M |
| Net Borrowing | -108.52M |
| Free Cash Flow | -108.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 21.13%, with operating and profit margins of 7.32% and 5.32%.
| Gross Margin | 21.13% |
| Operating Margin | 7.32% |
| Pretax Margin | 7.03% |
| Profit Margin | 5.32% |
| EBITDA Margin | 8.72% |
| EBIT Margin | 7.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.47% |
| Buyback Yield | 0.11% |
| Shareholder Yield | 2.01% |
| Earnings Yield | 5.07% |
| FCF Yield | -1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 15, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Anuh Pharma has an Altman Z-Score of 5.56 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.56 |
| Piotroski F-Score | 4 |